Effects of Roflumilast on Patients with Chronic Obstructive Pulmonary Disease Treated with Inhaled Corticosteroid/Long-Acting <i>β</i>2 Agonist: A Meta-analysis

<div>The quality assessment of the included literature: (a) overall bias risk; (b) bias risk for each RCT.</div>

Computational and Mathematical Methods in Medicine

fig2

Figure 2

Figure 2: Effects of Roflumilast on Patients with Chronic Obstructive Pulmonary Disease Treated with Inhaled Corticosteroid/Long-Acting <i>β</i>2 Agonist: A Meta-analysis 

Figure 2 | Effects of Roflumilast on Patients with Chronic Obstructive Pulmonary Disease Treated with Inhaled Corticosteroid/Long-Acting β2 Agonist: A Meta-analysis 